Učitavanje...
One gene to rule them all…and in the darkness bind them
Pharmaceutical inhibition of the Human Epidermal growth factor Receptor 2 (HER2) oncogene has dramatically improved outcomes in HER2-amplified breast cancers. However, monotherapy HER2 inhibitors are not effective. We have recently reported that a co-amplified microRNA within the HER2 amplicon, lead...
Spremljeno u:
| Izdano u: | Mol Cell Oncol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6149778/ https://ncbi.nlm.nih.gov/pubmed/30250918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2018.1465881 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|